Sun Pharma shares in focus after the latest USFDA action on its Halol facility

Halol is one of Sun Pharma’s key plants but has been under an import alert since December 2022, leading to the refusal of shipments from the site into the US, except for certain exempted products in cases of drug shortages.

Leave a Reply

Your email address will not be published. Required fields are marked *